Archer Investment Series Trust has released its annual shareholder report, which provides a comprehensive overview of the Archer Growth ETF's performance for the period ending August 31, 2026. This report is significant as it not only informs shareholders about the fund's performance but also reflects the company's commitment to transparency in its operations.
The Archer Growth ETF, listed under the trading symbol ARWG on the CBOE, is designed to offer investors exposure to growth-oriented investments. The report details the fund's performance metrics, operational updates, and insights into its management strategies, which are essential for both current and prospective investors.
Background
Archer Investment Series Trust is an investment company focused on managing mutual funds and exchange-traded funds (ETFs). The firm is registered under the Investment Company Act with the file number 811-22356. The company operates from Carmel, Indiana, and is known for its Archer Growth ETF, which aims to provide capital appreciation through a diversified portfolio.
What the Filing Says
The filing, dated November 5, 2026, outlines key performance indicators for the Archer Growth ETF, emphasizing its operational transparency. The report states, "This annual shareholder report contains important information about the Archer Growth ETF for the period of December 29, 2025, to August 31, 2026." This highlights the fund's performance during a critical fiscal year.
Impact
The release of this annual report may affect various stakeholders, including current shareholders, potential investors, and analysts within the investment management industry. As the report provides crucial insights into the fund's performance, it serves as a benchmark for investors to evaluate their holdings and make informed decisions.
What's Next
The filing does not specify what happens next regarding the Archer Growth ETF or any upcoming actions from Archer Investment Series Trust.
For more details, the full report can be accessed through the SEC's website, with the accession number 0001133228-26-013930.
Read Next
HSBC grants conditional awards to employees totaling 336,726 shares
Polestar Automotive to Convert to Dutch B.V. Structure
Kandal M Venture Regains Nasdaq Compliance After Price Surge
Genprex Announces Positive Results for Reqorsa in Aging Study
Precision BioSciences Advances Clinical Trials for HBV, DMD
OKYO Pharma to Present at Stifel 2026 Healthcare Conference










